Your browser doesn't support javascript.
loading
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Agarwal, Gaurav; Moore, Sally; Sadler, Ross; Varghese, Sherin; Turner, Alison; Chen, Lucia Y; Larham, Jemma; Gray, Nathanael; Carty, Oluremi; Barrett, Joe; Koshiaris, Constantinos; Kothari, Jaimal; Bowcock, Stella; Oppermann, Udo; Gamble, Vicky; Cook, Gordon; Kyriakou, Chara; Drayson, Mark; Basu, Supratik; McDonald, Sarah; McKinley, Shelagh; Gooding, Sarah; Javaid, Muhammad K; Ramasamy, Karthik.
Afiliación
  • Agarwal G; Division of Haematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Moore S; Bath Royal United Hospitals, Bath.
  • Sadler R; Oxford University Hospitals NHS Trust, Oxford.
  • Varghese S; Oxford University Hospitals NHS Trust, Oxford.
  • Turner A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Chen LY; Oxford University Hospitals NHS Trust, Oxford.
  • Larham J; Oxford University Hospitals NHS Trust, Oxford.
  • Gray N; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Carty O; Oxford University Hospitals NHS Trust, Oxford.
  • Barrett J; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Koshiaris C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford.
  • Kothari J; Oxford University Hospitals NHS Trust, Oxford.
  • Bowcock S; King's College Hospital NHS Trust, London.
  • Oppermann U; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Gamble V; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Cook G; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds.
  • Kyriakou C; University College London Hospitals NHS Trust, London.
  • Drayson M; University of Birmingham, Birmingham.
  • Basu S; The Royal Wolverhampton NHS Trust, Wolverhampton, UK; University of Wolverhampton, Wolverhampton.
  • McDonald S; Blood Cancer UK, London.
  • McKinley S; Myeloma UK, Edinburgh.
  • Gooding S; Oxford University Hospitals NHS Trust, Oxford, UK; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine.
  • Javaid MK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
  • Ramasamy K; Oxford University Hospitals NHS Trust, Oxford. karthik.ramasamy@ndorms.ox.ac.uk.
Haematologica ; 109(6): 1960-1965, 2024 06 01.
Article en En | MEDLINE | ID: mdl-38268439
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Italia